4
Changes in Ownership
MYRIAD GENETICS INC Filed Acc 0001219036-21-000024
Chief Scientific Officer sold 80,000 shares at an average $35.32 ($2,825,600)
- Chief Scientific Officer acquired 80,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LANCHBURY JERRY S · Chief Scientific Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-23 | Exercise or conversion : show line 1 in the form | +10,000 | $27.07 | $270,700 | 242,550 | D |
| 2021-08-23 | Sale : show line 2 in the form | −10,000 | $35.57 | $355,700 | 232,550 | D |
| 2021-08-23 | Exercise or conversion : show line 3 in the form | +40,000 | $27.07 | $1,082,800 | 272,550 | D |
| 2021-08-23 | Sale : show line 4 in the form | −40,000 | $35.07 | $1,402,800 | 232,550 | D |
| 2021-08-24 | Exercise or conversion : show line 5 in the form | +30,000 | $27.07 | $812,100 | 262,550 | D |
| 2021-08-24 | Sale : show line 6 in the form | −30,000 | $35.57 | $1,067,100 | 232,550 | D |
| Open-market sales · 80,000 sh · avg $35.32 · $2,825,600 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-23 | Exercise or conversion : show line 7 in the form Non-Qualified Stock Option (right to buy) | −10,000 | 70,000 | D |
| 2021-08-23 | Exercise or conversion : show line 8 in the form Non-Qualified Stock Option (right to buy) | −40,000 | 30,000 | D |
| 2021-08-24 | Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) | −30,000 | 0 | D |
Loading xslF345X03/edgardoc.xml…